Back to news archive

Gradientech starts clinical study in Europe

Gradientech announces the start of a clinical study of its diagnostic QuickMIC® system. The goal of the study is to validate the clinical performance of the system and it will form the basis for a regulatory CE-IVD approval. The QuickMIC system is developed with the aim to become the fastest diagnostic system on the market for rapid antibiotic susceptibility testing of sepsis samples.

Link to press-release